Netcracker Achieves Ready for ODA Status for Its BSS/OSS Portfolio
Netcracker Is One of the First Vendors to Adopt TM Forum’s Open Digital Architecture Principles…
2 years ago
Alex
Europe the cheapest region for entity management in 2023
Europe ranked as cheapest region for the second year running NA ranked best region for…
2 years ago
Trust Bank and Thales Launch Singapore’s First Ocean Plastic® Card
Trust Bank Singapore Limited (known as ‘Trust’), is offering its customers sustainable credit and debit…
2 years ago
International Students Visit China Eastern Airlines
SHANGHAI--(BUSINESS WIRE)--Nearly 30 overseas students joined an educational tour at R&D Center of China Eastern…
2 years ago
Nextracker Achieves 10-Gigawatt Milestone in Middle East, Africa, and India Solar Power Markets
DUBAI, United Arab Emirates--(BUSINESS WIRE)--Nextracker (Nasdaq: NXT), a leading global provider of intelligent solar tracker…
2 years ago
Zai Lab Announces the First Listing of VYVGART® (efgartigimod alfa injection) and Other Updates in China’s National Reimbursement Drug List
SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that the…
2 years ago
MoreLogin, the World’s #1 Antidetect Browser, Showcased at Affiliate World Asia (AWA)
MoreLogin, a pioneer in antidetect browser technology, highlights its unique solutions at Asia's largest affiliate…
2 years ago
Gunze Launches Environmentally Friendly “GEOPLASâ„¢ HCX1”, the Lightest Shrink Film for Automatic Sleeve Applicators
-New ways to reduce environmental impact with shrink film- OSAKA, Japan--(BUSINESS WIRE)--Gunze Limited (Headquarters: Osaka,…
2 years ago
Modalis and JCR Pharmaceuticals enter into joint research agreement
Modalis-JCR Pharmaceuticals Sign Joint Research Agreement TOKYO & WALTHAM, Mass.--(BUSINESS WIRE)--Modalis Therapeutics Corporation (Modalis) (Tokyo…
2 years ago
Suzhou OSAI Biopharma Announces Positive Phase III Clinical Trial Results for Lactobacillus Crispatus Live Bacteria Capsule, Significantly Reducing Recurrence of Gynecological Infections
SUZHOU, China--(BUSINESS WIRE)--Suzhou OSAI Biopharma, Inc., a biopharmaceutical company focused on developing live biotherapeutic products…
2 years ago